Cronos Group Inc. (CRON)
- Previous Close
2.4100 - Open
2.3700 - Bid 2.3600 x 100
- Ask 2.3700 x 100
- Day's Range
2.3400 - 2.4500 - 52 Week Range
1.6400 - 2.9900 - Volume
2,817,008 - Avg. Volume
2,951,517 - Market Cap (intraday)
901.772M - Beta (5Y Monthly) 1.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3000 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.61
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
www.thecronosgroup.com356
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CRON
Performance Overview: CRON
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRON
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRON
Valuation Measures
Market Cap
913.59M
Enterprise Value
54.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.48
Price/Book (mrq)
0.83
Enterprise Value/Revenue
0.63
Enterprise Value/EBITDA
-0.76
Financial Highlights
Profitability and Income Statement
Profit Margin
-84.78%
Return on Assets (ttm)
-4.24%
Return on Equity (ttm)
-6.30%
Revenue (ttm)
87.24M
Net Income Avi to Common (ttm)
-69.85M
Diluted EPS (ttm)
-0.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
861.53M
Total Debt/Equity (mrq)
0.23%
Levered Free Cash Flow (ttm)
-52.41M
Research Analysis: CRON
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: CRON
Analyst Report: Cronos Group Inc.
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
RatingNeutralPrice TargetAnalyst Report: Cronos Group Inc.
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
RatingBearishPrice TargetAnalyst Report: Cronos Group Inc.
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
RatingNeutralPrice TargetAnalyst Report: Cronos Group Inc.
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
RatingNeutralPrice Target